Back
VYNE Therapeutics, Inc. Vs. ACM Research, Inc. Industry Stock Comparison
Buy
70
VYNE
VYNE Therapeutics, Inc.
Last Price:
$0.57
Seasonality Move:
-5.82%
Buy
55
ACMR
ACM Research, Inc.
Last Price:
$44.89
Seasonality Move:
46.11%
Buy
70
VYNE Therapeutics, Inc. (VYNE)
is a Buy
Is VYNE Therapeutics, Inc. a Buy, Sell or Hold?
-
The current VYNE Therapeutics, Inc. [VYNE] share price is $0.58. The Score for VYNE is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
VYNE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
ACM Research, Inc. (ACMR)
is a Buy
Is ACM Research, Inc. a Buy, Sell or Hold?
-
The current ACM Research, Inc. [ACMR] share price is $39.45. The Score for ACMR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ACMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VYNE Stock Price Chart
What is VYNE Therapeutics, Inc.'s stock price today?
-
The VYNE Therapeutics, Inc. share price today is $0.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VYNE is experiencing slight selling pressure.
ACMR Stock Price Chart
What is ACM Research, Inc.'s stock price today?
-
The ACM Research, Inc. share price today is $39.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACMR is experiencing selling pressure, which indicates risk of future bearish movement.
VYNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 69.67 | Buy |
| Chaikin Money Flow: | 73570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.56) | Buy |
| Bollinger Bands (100): | (0.3 - 0.44) | Buy |
ACMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.4 | Buy |
| Relative Strength Index (14 RSI): | 57.65 | Buy |
| Chaikin Money Flow: | -971326 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.07 - 39.85) | Buy |
| Bollinger Bands (100): | (29.02 - 40.1) | Buy |
VYNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Buy |
| 20-day SMA: | 0.48 | Buy |
| 50-day SMA: | 0.41 | Buy |
| 200-day SMA: | 0.83 | Sell |
| 8-day EMA: | 0.53 | Buy |
| 20-day EMA: | 0.37 | Buy |
| 50-day EMA: | 0.19 | Buy |
| 200-day EMA: | 0.06 | Buy |
ACMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.84 | Sell |
| 20-day SMA: | 37.97 | Buy |
| 50-day SMA: | 36.41 | Buy |
| 200-day SMA: | 29.71 | Buy |
| 8-day EMA: | 39.58 | Sell |
| 20-day EMA: | 38.17 | Buy |
| 50-day EMA: | 36.59 | Buy |
| 200-day EMA: | 31.04 | Buy |
VYNE Therapeutics, Inc. Earnings Growth & VYNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and a decrease next year of $0.55 per share.
ACM Research, Inc. Earnings Growth & ACMR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.
VYNE Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ACM Research, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||